Amphotericin B liposome (CSPC)

两性霉素B脂质体 (石药)

Report date: 2026/05/06 20:02:28

Base Information

Drug NameAmphotericin B liposome (CSPC)
Drug Alias NameHC1507G2HC-1507G2
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionCell membrane permeability enhancersErgosterol binders
TargetsErgosterol
Therapy Area/IndicationsMycoses
Global Approved IndicationsMycoses
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2026/04/29
Country/TerritoryEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCSPC Pharmaceutical Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCSPC Pharmaceutical Group Ltd
Inactive CompaniesN/A
Active IndicationsMycoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A